| Conceptual Structures |
| ISA | DRUG
|
| SUBCLASSES | ALKALOID
ALKYLATING-DRUG
ANTIBIOTIC
ANTIMETABOLITE
BIOLOGICAL-RESPONSE-MODIFIER
COMBINATION-ANTICANCER-AGENT
HORMONAL-ANTICANCER-AGENT
MITOTIC-INHIBITOR
PALLIATIVE-DRUG
RADIOSENSITIZER
UNCLASSIFIABLE-CHEMOTHERAPEUTIC-AGENTS
|
| DESCENDANTS | ACE
ACETAMIDE
ACIVICIN
ACLACINOMYCIN
ACOPP
ACTINOMYCIN-D
ADOC
ALANINE
ALANOSINE
ALKALOID
ALKYLATING-DRUG
ALPHA-INTERFERON
ALTRETAMINE
AMSACRINE
ANALGESIC
ANGUIDINE
ANTHRAPYRAZOLE
ANTI-INFLAMMATORY-AGENT
ANTIANDROGEN
ANTIBIOTIC
ANTIDEPRESSANT
ANTIMETABOLITE
ANTIPSYCHOTIC-TRANQUILIZER-AGENT
ANTIPYRETIC
ANXIOLYTIC-AND-SEDATIVE
APHIDICOLIN-GLYCINATE
ASPARAGINASE
AZACYTIDINE
BENZISOQUINOLINEDIONE
BIOLOGICAL-RESPONSE-MODIFIER
BIPHENQUINATE
BISANTRENE-HYDROCHLORIDE
BLEOMYCIN
BRUCEANTIN
BUSULFAN
CABO
CAFFEINE
CAP
CARBOPLATIN
CARMUSTINE
CENTRAL-NERVOUS-SYSTEM-AGENT
CHAD
CHLORAMBUCIL
CHLOROZOTOCIN
CISCA
CISPLATIN
CLOMESONE
COCAINE
COMBINATION-ANTICANCER-AGENT
CYANOMORPHOLINO-ADR
CYCLOCYTIDINE
CYCLODISONE
CYCLOPHOSPHAMIDE
CYTARABINE
CYTOSINE
DACARBAZINE
DAUNORUBICIN
DECITABINE
DEOXYDOXORUBICIN
DEXAMETHASONE
DIANHYDROGALACTITOL
DIAZIQUONE
DIBENZYLDAUNORUBICIN
DICHLOROLAPACHOL
DIGLYCOALDEHYDE
DIHYDRO-5-AZACYTIDINE
DOXORUBICIN
EPIRUBICIN
ESTRAMUSTINE
ETHANESULFONIC-ACID
ETOPOSIDE
FAC
FAM
FLOXURIDINE
FLUOROFUR
FLUOROPAN
FLUOROURACIL
FLURACIL
FLUTAMIDE
GENERAL-ANESTHETIC
GUANAZOLE
GUANOSINE
HEPSULFAM
HORMONAL-ANTICANCER-AGENT
HYDRAZINECARBOTHIOAMIDE
HYDROXYUREA
IDARUBICIN
IFOSFAMIDE
IMIZADOLE-PYRAZOLE
INTERFERON
INTERLEUKIN-2
IPROPLATIN
L-ASPARAGINASE
L-ASPARTIC-ACID
LEUCINE
LEUKOVORIN
LEUPROLIDE
LEVAMISOLE
LOMUSTINE
M-2
M-BACOD
MACBECIN
MACC
MAP-ANTICANCER
MAYSANINE
MECHLORETAMINE
MEDROXYPROGESTERONE
MEGESTROL
MELPHALAN
MERCAPTOPURINE
MESNA
METHANESULFONATE
METHOTREXATE
METHYLNOGAROL
METHYLPREDNISOLONE
MITOMYCIN
MITOTANE
MITOTIC-INHIBITOR
MITOXANTRONE
MITOZOLOMIDE
MORPHINE
MORPHOLINO-ADR
NEOCARZINOSTATIN
NICOTINE
NITROGEN-MUSTARD
NITROSUREA
OPIATE-AGONIST
OXANTHRAZOLE
PACLITAXEL
PALLIATIVE-DRUG
PENTOSTATINE
PHENACETIN
PIPERAZINE-ALKYLATOR
PIPERAZINEDIONE
PIPOBROMAN
PLATINATE
PREDNISONE
PROCARBAZINE
PROPANE
PROPANOL
PSYCHOTHERAPEUTIC-AGENT
PYRAZOFURIN
PYRAZOLOACRIDINE
PYRIDINE-2-CARBOXALDEHYDE
RADIOPROTECTOR
RADIOSENSITIZER
RAPAMYCIN
RHIZOXIN
RUBIDAZONE
SPIROHYDANTOIN-MUSTARD
STIMULANT
TAMOXIFEN
TENIPOSIDE
TEROXIRONE
TETRAPLATIN-PLATINUM
THIADIAZOLE
THIOGUANINE
THIOGUANOSINE
THIOTEPA
THYMOSIN
TRETAMINE
TRIMETREXATE
UNCLASSIFIABLE-CHEMOTHERAPEUTIC-AGENTS
URACIL-NITROGEN-MUSTARD
VINBLASTINE
VINCRISTINE
VINDESINE
|
| ANCESTORS | ALL
DRUG
MATERIAL
OBJECT
PHARMACEUTICAL-MATERIAL
PHYSICAL-OBJECT
THERAPEUTICAL-MATERIAL
|
INHERITED
RELATIONS | CONTAINED-IN : PHYSICAL-OBJECT (from PHYSICAL-OBJECT)
MANUFACTURED-CONTAINER (by default) (from PHYSICAL-OBJECT)
ELEMENT-OF : COLLECTION (from OBJECT)
HAS-ACRONYM : RYLIC-PAINT (by default) (from DRUG)
HAS-TRADENAME : TRADE-NAME (by default) (from DRUG)
INSTRUMENT-OF : MEDICATE (by default) (from DRUG)
CANCER-TREATMENT (by default) (from DRUG)
LOCATION : PLACE (from PHYSICAL-OBJECT)
MADE-OF : MATERIAL (from MATERIAL)
MATERIAL-OF : DRUG (by default) (from PHARMACEUTICAL-MATERIAL)
MEASURED-BY : MEASURING-ARTIFACT (from MATERIAL)
MERCHANDISE-OF : DRUGSTORE (by default) (from DRUG)
OBJECT-NAME : NAME (from PHYSICAL-OBJECT)
OWNED-BY : HUMAN (from PHYSICAL-OBJECT)
PART-OF : OBJECT (from OBJECT)
PRODUCT-TYPE-OF : LABORATORY-PHARMACEUTICAL (by default) (from DRUG)
HEALTH-CARE-ORGANIZATION (from DRUG)
SUBSTRATE-OF : MOTION-EVENT (from MATERIAL)
THEME-OF : EVENT (from MATERIAL)
USED-IN : CANCER-TREATMENT (from DRUG)
USED-IN-THE-TREATMENT-OF : DISEASE-EVENT (from PHARMACEUTICAL-MATERIAL)
HAVE-NEOPLASM (from PHARMACEUTICAL-MATERIAL)
|
INHERITED
ATTRIBUTES | AGE : >0 (from MATERIAL)
COLOR : MAGENTA (from MATERIAL)
CYAN (from MATERIAL)
RED (from MATERIAL)
ORANGE (from MATERIAL)
NAVY-BLUE (from MATERIAL)
TAN (from MATERIAL)
YELLOW (from MATERIAL)
GREEN (from MATERIAL)
GRAY (from MATERIAL)
BLUE (from MATERIAL)
PURPLE (from MATERIAL)
SIZE : <=0>=1000000 (from PHYSICAL-OBJECT)
STATE-OF-MATTER : LIQUID (from PHARMACEUTICAL-MATERIAL)
SOLID (from PHARMACEUTICAL-MATERIAL)
TOXICITY : Low (from DRUG)
Medium (from DRUG)
High (from DRUG)
WAY-OF-ADMINISTRATION : oral (from DRUG)
injection (from DRUG)
|